Tesla’s big Model 3 bet rides on risky assembly line strategy
April 24 Tesla Inc Chief Executive Elon Musk took many risks with the technology in his company's cars on the way to surpassing Ford Motor Co's market value.
Nov 29 Kempharm Inc :
* Kempharm receives clearance from FDA to initiate clinical program for KP201/IR, a single-entity benzhydrocodone HCL immediate release abuse-deterrent prodrug for the treatment of acute pain
* Kempharm expects to conduct human clinical trials of KP201/IR in 2017
* Intend to initiate human clinical trials of KP201/IR in first half of 2017
* Remain on target for a potential submission in 2018 of KP201/IR new drug application Source text for Eikon: Further company coverage:
* Thousands of "zama zamas" mine gold illegally in South Africa
April 24 The following are the top stories on the New York Times business pages. Reuters has not verified these stories and does not vouch for their accuracy.